SVP, General Counsel and Sec. · Dianthus Therapeutics, Inc. /DE/ · Common Stock
Side
M
Value
$69K
Shares
3,833
Price
$17.88
Executed
Aug 7, 2026
Disclosed
Aug 11, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 7 executedAug 11, 2026 disclosed
DNTH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+4 / 25
$69K reported value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Veness Adam M filed this Form 4 reporting a option exercise of DNTH on Aug 7, 2026. It became public on Aug 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, General Counsel and Sec.
Veness Adam Mcik:0001778623
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
